<DOC>
	<DOCNO>NCT00002873</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy may kill tumor cell remain surgery . PURPOSE : Phase I/II trial study effectiveness brachytherapy treat woman stage I stage II breast cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Women With Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate technical feasibility reproducibility , cosmetic result , complication rate , local cancer control rate experience brachytherapy use sole method radiotherapy woman stage I/II breast cancer treat tylectomy histologically assessed negative surgical margin , le 4 positive axillary node , extracapsular nodal extension extensive intraductal component . II . Reduce total treatment time breast irradiation 6 week 4-5 day patient . OUTLINE : Treatment begin sooner 4 day within 6 week definitive surgery . All patient receive brachytherapy target volume ( defined excision cavity demarcate post-tylectomy surgical clip plus 2 cm margin ) use iridium-192 implant dose distribution five plane . Patients may treat either high-dose-rate low-dose-rate brachytherapy institution 's discretion . Patients follow 2 6 week treatment , 3 , 6 , 9 12 month , every 4 month 1 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A maximum 46 patient accrue group ( high-dose rate v low-dose rate ) 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nonlobular invasive breast cancer one follow histology : Ductal Papillary Medullary Colloid ( mucinous ) Tubular Stage I/II ( T12 N01 M0 ) tumor great 3 cm Prior tylectomy axillary lymph node dissection require No 3 positive axillary lymph node extracapsular extension At least 6 lymph node sample OR Negative sentinal node Surgical clip place delineate margin tylectomy cavity Negative , close negative , inked histologic margin tylectomy reexcision specimen Negative margin define tumor least 2 mm away inked margin Close negative margin define tumor within 2 mm ink margin Positive margin define invasive noninvasive tumor ink resection margin Negative posttylectomy postreexcision mammogram require disease present malignancyassociated microcalcifications No remain suspicious microcalcifications If catheter place time reexcision , crieria may feasible post brachytherapy mammogram obtain soon possible No extensive intraductal carcinoma Harvard definition , i.e . : More 25 % tumor ductal carcinoma situ ( DCIS ) DCIS adjacent breast tissue OR Intraductal carcinoma microinvasion No proven multicentric carcinoma , i.e . : Tumor different quadrant breast OR Tumor separate least 4 cm The following exclude : Skin chest wall invasion Matted fix axillary adenopathy Metastatic internal mammary supraclavicular node Paget 's disease nipple Previously treat contralateral breast carcinoma synchronous bilateral breast carcinoma Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Any age Sex : Female Menopausal status : Not specify Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No collagen vascular disease creactive protein level normal active skin rash ( e.g. , systemic lupus erythematosus , scleroderma , dermatomyositis ) No coexist medical condition reduces life expectancy le 2 year No second malignancy within 5 year except nonmelanomatous skin cancer Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy breast cancer Planned chemotherapy may begin least 2 week removal brachytherapy catheter Endocrine therapy : Concurrent tamoxifen permit Radiotherapy : No prior radiotherapy breast cancer Surgery : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>medullary ductal breast carcinoma lymphocytic infiltrate</keyword>
	<keyword>mucinous ductal breast carcinoma</keyword>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>papillary ductal breast carcinoma</keyword>
	<keyword>tubular ductal breast carcinoma</keyword>
</DOC>